Veterinary Medicine Information website

BioBos Respi 3 vakcina A.U.V.

Authorised
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
Download as PDF

Product identification

Medicine name:
BioBos Respi 3 vakcina A.U.V.
Active substance:
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)/dose
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)/dose
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alphavet Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: